A new study suggests that depression may leave detectable signs in aging immune cells found in the blood. Researchers say these findings could move science closer to creating an objective biological test for depression in the future.
The research was published in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.
Depression affects millions of people around the world and can have serious effects on emotional health, physical health, relationships, and daily life. Yet diagnosing depression is often difficult because there is currently no medical scan, blood test, or laboratory measurement that can clearly confirm the condition.
Instead, doctors rely mostly on conversations with patients and symptom questionnaires.
One challenge is that depression can appear very differently from person to person. Some people mainly feel emotionally numb, hopeless, or unable to enjoy life. Others experience more physical symptoms such as poor sleep, low energy, appetite changes, or body restlessness.
Researchers have long searched for biological markers that might help doctors better understand these differences.
The new study focused on biological aging and the immune system.
Scientists already know that chronic stress, inflammation, and mental health conditions can affect how the body ages at the cellular level. Sometimes the body’s cells appear biologically older than expected for a person’s actual age.
To study this process, researchers use epigenetic clocks, which measure chemical changes in DNA that happen over time.
The study involved 440 women from the Women’s Interagency HIV Study. Among them, 261 women were living with HIV and 179 did not have HIV.
Researchers included women with HIV because depression is especially common among people living with chronic immune-related illnesses. Scientists believe inflammation, social stress, economic hardship, and long-term health challenges may all contribute to higher depression risk in these populations.
Participants completed a depression questionnaire that measured both emotional and physical symptoms.
Researchers then analyzed blood samples to examine biological aging in immune cells.
The scientists paid special attention to monocytes, a type of white blood cell involved in inflammation and immune defense. Monocytes are important because they help regulate immune responses and may become overactive during chronic inflammation.
The study found that faster aging in monocytes was strongly linked to emotional and cognitive symptoms of depression.
Women with more aged monocytes were more likely to experience symptoms such as hopelessness, feelings of failure, and anhedonia, which means losing interest or pleasure in activities that once felt enjoyable.
Surprisingly, the researchers did not find the same strong link with physical symptoms like fatigue or appetite changes.
The researchers also tested a broader biological aging measure that examined multiple cell types throughout the body. That larger measurement did not show the same relationship with depression symptoms.
This suggests that specific immune cells may provide more accurate clues about mental health than general biological aging markers.
Scientists say the findings may eventually help improve depression diagnosis and treatment.
If future studies confirm the results, doctors might someday combine traditional mental health evaluations with biological testing to identify depression earlier and more precisely.
Researchers also hope biological markers could eventually help guide personalized treatment decisions. Different biological patterns may explain why some patients respond well to certain antidepressants or therapies while others do not.
However, the scientists stress that much more research is still needed. The study does not mean a blood test for depression is ready for hospitals or clinics.
Researchers still need to study larger populations and determine whether the immune changes actually contribute to depression or simply occur alongside it.
The findings do add to a growing body of evidence linking mental health to inflammation and immune system activity. Scientists increasingly believe that depression is not only a brain disorder but may also involve the body’s broader biological systems.
Reviewing the study overall, the research appears promising because it used biological measurements alongside psychological symptom data, helping bridge the gap between mental health and physical biology.
The focus on emotional and cognitive symptoms rather than physical symptoms also adds an important new perspective to depression research. However, the findings remain preliminary, and the study cannot yet establish whether immune cell aging causes depression or results from it.
Future long-term studies will be essential before any clinical blood test becomes possible. Still, the research offers hope that mental health care may eventually become more objective, personalized, and biologically informed.
Source: NYU Rory Meyers College of Nursing.
